Navigation Links
Hematology in Medical Technology

Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients

... Data at the 14th Congress of the European hematology Association Showing High Response Rate in ... (MT103) at the 14th Congress of the European hematology Association (EHA) in Berlin, Germany, showing a ... presented at the 14th Congress of the European hematology Association. The webcast will be available on ...

Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients

... Data Presented at Meeting of European hematology Association Confirms High Response Rate and ... (NHL) at the 14th Congress of the European hematology Association (EHA), held June 4 to 7 in Berlin, ... presented at the 14th Congress of the European hematology Association. The webcast will be available on ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... 50th Annual Meeting of the American Society of hematology in San Francisco, CA. Additional research being ... University Medical School, St. Louis, MO. "The hematology community is committed to continuously improving ... of Americans every year, the American Society of hematology has developed a new resource, ...

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

... 50th Annual Meeting of the American Society of hematology in San Francisco, CA. Preliminary results from a ... all outcomes. American Society of hematology 50th Annual Meeting The study authors and ... cell disease. The American Society of hematology ( www.hematology.or g ) is the world's largest ...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

... 50th Annual Meeting of the American Society of hematology in San Francisco, CA. Results from a ... Berliner, M.D., 2009 ASH President and Chief of hematology at Brigham and Women's Hospital in Boston and ... -- induced anemia. American Society of hematology 50th Annual Meeting The study ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... 50th Annual Meeting of the American Society of hematology in San Francisco, CA. Two other studies on ... Berliner, MD, 2009 ASH President and Chief of hematology at Brigham and Women's Hospital in Boston. "These ... conference will provide a preview of the new hematology documentary "Blood Detectives," which will ...

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

... 50th Annual Meeting of the American Society of hematology in San Francisco, CA. The studies featured in the ... MD, 2008 President of the American Society of hematology and Helen M. Ranney Professor and Chair of the ... mild to moderate. American Society of hematology 50th Annual Meeting The study ...

Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

... Fatigue Presentation at the European hematology Association 13th Congress CHESHIRE, Conn., June ... according to data presented today at the European hematology Association (EHA) 13th Congress in Copenhagen ... Presented at 13th Congress of the European hematology Association Annual Meeting; June 15, 2008; ...

MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule

... Data Presented at the 49th American Society of hematology (ASH) Meeting ATLANTA, Dec. 11 ... Meeting and Exposition of the American Society of hematology (ASH) in Atlanta. "The data from this study ... innovative products for the treatment of hematology and oncology patients in the U.S., Europe ...

PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity

... Data Presented at the American Society of hematology (ASH) Annual Meeting ... 49th Annual Meeting of the American Society of hematology Meeting in Atlanta. The data were highlighted ... Annual Meeting of the American Society of hematology Meeting. December 11, 2007. (2) Rother RP, Bell ...

PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide

... Meeting, to be held May 29 - June 2, 2009 in Orlando, Florida. PAREXEL's hematology and oncology experts will be available during the ASCO meeting at Booth ... Medical Director, Clinical Research Services, PAREXEL. "Our global team of hematology and oncology experts helps clients advance important innovations through ...

Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis

... Albitar, M.D., Medical Director and Chief of Research and Development, hematology and Oncology, and Wanlong Ma, M.S., Research and Development Manager, hematology and Oncology. For the study, Dr. Albitar and Ms. Ma developed a ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... in Early Chronic Phase (CML-CP). Abstract # 446. American Society of hematology 2008 Annual Meeting, San Francisco, CA. (2) Rosti G, et al. High ... of the GIMEMA CML Working Party. Abstract # 181. American Society of hematology 2008 Annual Meeting, San Francisco, CA. (3) Gleevec(R) (imatinib ...

New Study Shows PCR and FCR Have Significant Activity in B-cell Chronic Lymphocytic Leukemia

... Oncology Center at the 50th Annual Meeting of the American Society of hematology (ASH) held December 6-9, 2008 in San Francisco. Dr. Reynolds is the lead ... will be presented at the 50th Annual Meeting of the American Society of hematology on December 8, 2008 at 11:30 a.m. PST. Physician researchers ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... data were presented at the 50th Annual Meeting of the American Society of hematology (ASH), held December 5-9, 2008 in San Francisco, California. ... which were presented by Michele Cavo, M.D., Seragnoli Institute of hematology and Medical Oncology, showed: -- The two-year PFS was 90 percent ...

Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH

... were presented today at the 50th Annual Meeting of the American Society of hematology in San Francisco in a poster session titled, "Safety and Efficacy of the ... United States and Europe," said Yuzuru Kanakura, M.D., Ph.D., Professor of hematology and Oncology at Osaka University Hospital in Suita, Japan, and lead author ...

Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology

... will be presented at the 50th Annual Meeting of the American Society of hematology (ASH) from December 6-9, 2008 in San Francisco, California. Clinical investigators from leading oncology and hematology research centers will present data through several oral and poster ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... with the oncology community. The American Society of hematology (ASH) annual meeting, beginning December 6th in San Francisco, CA, will ... pleased that our ongoing work with experts in the fields of oncology and hematology continue to provide valuable new insights across multiple cancer types." ...

BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease

... forties," said Lewis Hsu, M.D., Ph.D., Associate Professor of Pediatric hematology & Interim Director of Marian Anderson Comprehensive Sickle Cell Center, ... PAT score for statistical purposes. Abstract at American Society of hematology Conference Abstract: Peripheral Arterial Tonometry Assessment of ...

Protein Key to Control Growth of Blood Cells

... for treating blood disorders," said study leader Wei Tong, Ph.D., a hematology researcher at The Children's Hospital of Philadelphia. Her study appeared ... were Alexey Bersenev, Chao Wu, and Joanna Balcerek, all of the Division of hematology at The Children's Hospital of Philadelphia. About The Children's ...

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

... data also will be delivered by Dr. Erba at the upcoming European hematology Association meeting in Copenhagen, Denmark on Sunday, June 15. Study ... in the United Kingdom and presented at earlier American Society of hematology meetings. Clolar Clinical Development A separate, phase 3 pivotal ...

Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany

... Einsele from the Allogeneic Stem Cell Transplant Center, Division of hematology and Oncology, Department of Internal Medicine II at the ... phase II clinical study for ATIR(TM) as principal investigator at the hematology Branch of the National Heart, Lung and Blood Institute (NHLBI) at the ...

Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress

... leukemia patients will be presented at the 13th Congress of the European hematology Association (EHA) being held June 12 - 15, 2008 in Copenhagen, Denmark. ... 8:00 a.m. - 12:00 p.m. CST, S Hall A1 13th Congress of the European hematology Association o SAFETY AND EFFICACY EXPERIENCE OF SNS-595 IN ...

Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency

... multiple myeloma," said Professor Philippe Moreau, Professor of Clinical hematology at Nantes Faculty of Medicine and Chairman of the Intergroupe Francophone ... developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international ...

Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

... for patients with higher-risk MDS," said Pierre Fenaux, M.D., Professor of hematology at the University of Paris, and Head, Department of Clinical Hematology, ... developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international ...

Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

... Data from the ongoing study, presented at the American Society of hematology (ASH) annual meeting last month, reported an objective complete and ... developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international ...

Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML

... before recommencing the trial. Dr. Frank Giles, Chief of the Division of hematology and Medical Oncology at the University of Texas Health Science Center at ... study were presented at the 2007 Annual Meeting of the American Society of hematology (ASH(R)) in December 2007. Conference Call Details Vion will hold a ...

Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH

... Anemia in PNH Patients Data Presented at the American Society of hematology (ASH) Annual Meeting Posters: 897-III & 891-III ... studies in patients with PNH presented today at the American Society of hematology (ASH) Meeting in Atlanta indicated that long-term treatment with ...

Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission

... Updated Phase 3 Results Released at American Society of hematology Meeting BERKELEY HEIGHTS, N.J., Dec. 10 /PRNewswire-FirstCall/ -- ... this weekend at a press briefing sponsored by the American Society of hematology (ASH) and will be presented in a scientific session on Tuesday December ...

TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma

... Study Presented at 49th American Society of hematology Meeting FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. ... study were presented at the 49th Annual Meeting of the American Society of hematology (ASH) in Atlanta, GA [Poster # 505-I; Abstract #1351]. "The high ...

Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood

... to be presented at the 49th Annual Meeting of the American Society of hematology in Atlanta, GA, will provide important insight into the treatment ... http://www.hematology.org/meetings/2007 . The American Society of hematology (http://www.hematology.org ) is the world's largest professional society ...

ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients

... Oct. 22 /PRNewswire-USNewswire/ -- Today, the American Society of hematology (ASH) and the American Society of Clinical Oncology (ASCO) have released ... in print in both journals on December 1. The American Society of hematology ( http://www.hematology.org ) is the world's largest professional society ...

Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints

... will be presented at the December 2007 meeting of the American Society of hematology (ASH) in Atlanta, Georgia. "An approval in front-line multiple myeloma ... in previous VELCADE clinical trials. Professor Jesus San Miguel, M.D., hematology Department Head, University Hospital of Salamanca, Spain, is the ...

Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)

... said Dr. Lewis R. Silverman, Associate Professor of Medicine, Division of hematology and Medical Oncology, Mount Sinai School of Medicine. "Building on ... options for higher-risk MDS," said Dr. Alan F. List, Chief, Malignant hematology Division and Deputy Physician in Chief, H. Lee Moffitt Cancer Center and ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... providing comprehensive cancer care in the greater Triangle area for 30 years. Beginning as a single physician practice, originally named Raleigh hematology Oncology, CCNC has grown to a physician staff of thirteen medical oncologists, two radiation oncologists, a head and neck surgical oncologist and a ...

Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome

... results from a separate Phase 1-2a study in MDS patients involving an intravenous formulation of TELINTRA were published earlier in the Journal of hematology and Oncology, 13 May 2009; Vol. 2, No.20, pp. 20-32. The findings reported from these studies support the further development of TELINTRA. Phase 2 ...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

... Study Evaluating Safety of DU-176b Compared with Warfarin in Subjects with Non-Valvular Atrial Fibrillation," presented at American Society of hematology annual meeting in December 2008. (2) Edoxaban tosylate is also known as DU-176b. (3) Schulman S., et al. Definition of major ...

Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options

... The ASCO summaries are "quick read" reviews of key oral sessions and poster presentations, which are handpicked by leading experts in oncology and hematology for the Clinical Care Options website. About Cell Therapeutics, Inc. Headquartered in Seattle, CTI is a biopharmaceutical company committed ...

Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections

... Importantly, there were no study discontinuations due to adverse events. Laboratory results showed no significant shifts from baseline in hematology or chemistry parameters, including platelets or liver enzymes. "The efficacy and safety of torezolid in this trial demonstrate its potential ...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

... currently available to reduce this risk(4,5). The Phase II open-label trial of 145 lymphoma patients was presented at the 14th annual European hematology Association congress in Berlin, Germany. Results show that 33% of patients with relapsed NHL and Hodgkin's disease treated with everolimus ...
Other Contents
(Date:7/11/2014)... The University of Chicago is creating a new ... at the University,s Institute for Molecular Engineering and ... million donation from the Millicent and Eugene Bell ... will reside within the Institute for Molecular Engineering. ... research project at the MBL,s Eugene Bell Center ...
(Date:7/11/2014)... July 10, 2014---A team of researchers from The Chinese ... identified a gene of wild soybean linked to salt ... grow in saline soil. This study published online in ... unveil novel genomic information for crop improvement. , Soybean ... domestication and human selection, cultivated soybeans have less genetic ...
(Date:7/11/2014)... have explored two different ways that allow unprecedented ... the formation of oxygen molecules in photosynthesis. The ... journal Nature Communications . , "The new ... for water oxidation, which are key components for ... of solar energy in fuels like hydrogen, ethanol ...
Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2BGI reports a novel gene for salt tolerance found in wild soybean 2Molecular snapshots of oxygen formation in photosynthesis 2
(Date:7/14/2014)... Love Digits LLC has successfully launched its ... App brings ancient astrology to the modern dating scene, ... using a five-star rating system. By entering their birth ... their compatibility for love and marriage across seven different ... rating system generates a weighted average of the seven ...
(Date:7/14/2014)... WA (PRWEB) July 14, 2014 ... solutions, today announced its new IBM i (AS/400, ... Software Vendors (ISVs). As security threats evolve and ... software providers struggle to modernize their applications and ... program now makes it easy for ISVs on ...
(Date:7/13/2014)... Florida (PRWEB) July 14, 2014 Save the ... Wolfson Children’s Hospital in Jacksonville, FL , BOXWOODS & BowTies ... 5-7, 2014 , Who: The Women’s Board of Wolfson ... & Antiques Show to continue their ongoing commitment to ... the region’s children. , What: The 2014 Art & ...
(Date:7/13/2014)... TopDresses100.com, a popular dress company in the global market, ... dresses to its product line. According to the ... guaranteed to be quality made. Now, they are offered ... has a wide variety of elegant dresses for customers ... stock and ready to ship. As an innovation-based supplier, ...
(Date:7/13/2014)... July 14, 2014 Recently, iFitDress.com, one ... has released its beautiful collection of brown evening ... outfits are now available at discounted prices, up to ... are of high quality; they are carefully made according ... special occasion gowns, iFitDress.com also offers pretty accessories: wedding ...
Breaking Medicine News(10 mins):Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 2Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 3Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 4Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 5Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 6Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 7Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 8Health News:Save the Date for the 2014 Art & Antiques Show benefiting Wolfson Children's Hospital in Jacksonville, FL 9Health News:Cheap Multi-colored Quinceanera Dresses From TopDresses100.com 2Health News:2014 Brown Evening Dresses Added To iFitDress.com 2
Other TagsOther Tags